Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05516862 · ClinicalTrials.gov registry record · NA

Determining the Right Acupuncture for Good Recovery Over Neuropsychiatric Trauma

A NA study of PTSD and Post Traumatic Stress Disorder, sponsored by Paul Crawford.

Recruiting
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT05516862 is a NA study of PTSD and Post Traumatic Stress Disorder that is actively recruiting participants, run by Paul Crawford. The registered enrollment target is 75 participants, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05516862, a NA study of PTSD and Post Traumatic Stress Disorder, is actively recruiting participants, sponsored by Paul Crawford.

RECRUITING
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

This study seeks to verify that a specific acupuncture treatment is effective at reducing symptoms of neuropsychiatric trauma found in those diagnosed with Post-Traumatic Stress Disorder (PTSD).

Interventions

  • OTHER Dragons acupuncture
  • OTHER Dragons acupressure
  • OTHER Dragons placebo

Study Locations (1)

Nevada

  • Mike O'Callaghan Military Medical Center - Nellis Air Force Base

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2022-10-01
Est. Completion 2026-10-01
Phase NA

Sponsor

Paul Crawford

6 total trials

What the Registry Record Tells You About NCT05516862

The ClinicalTrials.gov registry entry for NCT05516862 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 301-participant average among 154 other PTSD trials with a reported enrollment target (75% lower). The listed sponsor is Paul Crawford, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with PTSD appearing as the primary indexed condition, and to 3 interventions - of which Dragons acupuncture is the first listed.

NCT05516862 reports 1 study location spanning 1 distinct geographic area - top geographies include Nevada.

Frequently Asked Questions

What is clinical trial NCT05516862 about?

NCT05516862 is a clinical study titled "Determining the Right Acupuncture for Good Recovery Over Neuropsychiatric Trauma". This study seeks to verify that a specific acupuncture treatment is effective at reducing symptoms of neuropsychiatric trauma found in those diagnosed with Post-Traumatic Stress Disorder (PTSD).

What is the current status of trial NCT05516862?

This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2022-10-01. Estimated completion is 2026-10-01.

What conditions does trial NCT05516862 study?

This clinical trial studies the following conditions: PTSD, Post Traumatic Stress Disorder, Acupuncture.

What interventions are being tested in trial NCT05516862?

The interventions under investigation include: Dragons acupuncture (OTHER), Dragons acupressure (OTHER), Dragons placebo (OTHER).

Who is sponsoring clinical trial NCT05516862?

This trial is sponsored by Paul Crawford, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05516862 being conducted?

This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PTSD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.